Biotechnology
Pharmaceuticals
Medical Devices
What we do
We help clients to understand and navigate the complexities of market access in biotechnology, medical devices and pharmaceuticals. With global reach and unrivalled expertise, we are uniquely placed to help clients to create and maximise the value of their assets though commercially focused market access strategies.
Pricing Reimbursement and Market Access
Strategy development
- Develop global and regional pricing strategy
- Qualitative and quantitative payer research
- Therapeutic area Payer advisory boards
- International Reference Pricing (IRP) & launch strategy
- Individual case study & benchmark analysis
- Secondary market research using big data analytics
Strategy implementation
- Bespoke IRP database & price tracking system
- Local country/regional dossier preparation
- Management of local reimbursement process
- Stakeholder & influencer mapping
- KoL development
- Patient advocacy
.
Health Economic and Outcomes Research (HEOR)
- Burden of illness study
- Cost effectiveness evaluation
- Global Value Dossier
- Clinical trial design to maximise value of asset
- Observational studies
- Testing & evaluation of economic models
- Health Technology Assessment advisory boards
Asset Evaluation and Due Diligence
- Investment strategy and portfolio-asset evaluation
- Competitive landscape assessment
- Global value proposition
- Product valuations for out-licensing
- Comprehensive due diligence documents